P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
APLT | N/A | N/A | N/A | +3.57% |
APLT Peer | N/A | N/A | N/A | -92.55% |
Pharmaceuticals: Major Industry | 23.1 | 15.7 | 0.3 | +51.75% |
Health Technology Sector | 32.3 | 21.1 | 0.6 | +117.04% |
S&P 500 Market | 32.4 | 31.4 | 1.1 | +100.04% |
Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
---|---|---|---|---|
Mean Estimate | -$0.76 | -$0.62 | -$0.53 | -$0.46 |
Previous Mean | -$0.76 | -$0.62 | -$0.53 | -$0.46 |
Standard Deviation | 0.24 | 0.24 | 0.18 | N/A |
Low Estimate | -$1.07 | -$0.92 | -$0.81 | -$0.46 |
High Estimate | -$0.48 | -$0.41 | -$0.36 | -$0.46 |